MGX peer analysis
Metagenomi Therapeutics (MGX) against its competitors: price, today's move, 1-year return and market value side by side.
- MGX's peers: ALXO (ALX Oncology), ARTV (Artiva Biotherapeutics), ATYR (aTyr Pharma), CNTB (Connect Biopharma), DTIL (Precision BioSciences), IFRX (InflaRx), KLRS (Kalaris Therapeutics), STRO (Sutro Biopharma).
MGX and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ALXO ALX Oncology | $1.06 | 3.92% | -27.89% | $137.03M |
| ARTV Artiva Biotherapeutics | $3.82 | -0.26% | 12.68% | $188.83M |
| ATYR aTyr Pharma | $3.69 | -9.56% | 446.50% | $9.05M |
| CNTB Connect Biopharma | $0.63 | -5.56% | -80.06% | $40.51M |
| DTIL Precision BioSciences | $7.40 | 7.09% | 53.53% | $206.72M |
| IFRX InflaRx | $1.02 | -6.42% | -19.05% | $150.32M |
| KLRS Kalaris Therapeutics | $1.35 | -1.46% | -79.79% | $32.14M |
| STRO Sutro Biopharma | $8.60 | -1.38% | -5.49% | $142.77M |
| MGX Metagenomi Therapeutics | $0.61 | -2.85% | -61.88% | $23.21M |